206 related articles for article (PubMed ID: 22863531)
21. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus core protein-induced miR-93-5p up-regulation inhibits interferon signaling pathway by targeting IFNAR1.
He CL; Liu M; Tan ZX; Hu YJ; Zhang QY; Kuang XM; Kong WL; Mao Q
World J Gastroenterol; 2018 Jan; 24(2):226-236. PubMed ID: 29375208
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
24. HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.
Luquin E; Larrea E; Civeira MP; Prieto J; Aldabe R
Antiviral Res; 2007 Nov; 76(2):194-7. PubMed ID: 17675168
[TBL] [Abstract][Full Text] [Related]
25. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
Sun LJ; Yu JW; Wan L; Zhang XY; Shi YG; Chen MY
Int J Infect Dis; 2014 Jun; 23():75-81. PubMed ID: 24704332
[TBL] [Abstract][Full Text] [Related]
27. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells.
Yao L; Yan X; Dong H; Nelson DR; Liu C; Li X
Virol J; 2011 Sep; 8():445. PubMed ID: 21936899
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cells inhibit hepatitis C virus expression.
Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
[TBL] [Abstract][Full Text] [Related]
29. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
30. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
31. STAT1 is essential for the inhibition of hepatitis C virus replication by interferon-λ but not by interferon-α.
Yamauchi S; Takeuchi K; Chihara K; Honjoh C; Kato Y; Yoshiki H; Hotta H; Sada K
Sci Rep; 2016 Dec; 6():38336. PubMed ID: 27929099
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
[TBL] [Abstract][Full Text] [Related]
33. Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.
Ganesan M; Zhang J; Bronich T; Poluektova LI; Donohue TM; Tuma DJ; Kharbanda KK; Osna NA
Am J Physiol Gastrointest Liver Physiol; 2015 Oct; 309(7):G566-77. PubMed ID: 26251470
[TBL] [Abstract][Full Text] [Related]
34. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
Erickson AK; Seiwert S; Gale M
Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum.
Benedicto I; Molina-Jiménez F; Barreiro O; Maldonado-Rodríguez A; Prieto J; Moreno-Otero R; Aldabe R; López-Cabrera M; Majano PL
Hepatology; 2008 Oct; 48(4):1044-53. PubMed ID: 18802961
[TBL] [Abstract][Full Text] [Related]
36. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
37. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
38. Alcohol attenuates anti-HCV function of IFN-λ1 through up-regulation of PLASy expression in human hepatic cells.
Ran M; Huang J; Liang H; Jiang J; Liang B; Ning C; Zang N; Liao W; Liu H; Qin F; Yang Q; Ho W; Ye L; Chen H
J Med Virol; 2018 Jun; 90(6):1112-1120. PubMed ID: 29446489
[TBL] [Abstract][Full Text] [Related]
39. Activation of interferon-stimulated response element in huh-7 cells replicating hepatitis C virus subgenomic RNA.
Pai M; Prabhu R; Panebra A; Nangle S; Haque S; Bastian F; Garry R; Agrawal K; Goodbourn S; Dash S
Intervirology; 2005; 48(5):301-11. PubMed ID: 15956798
[TBL] [Abstract][Full Text] [Related]
40. Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV.
Stevenson NJ; Murphy AG; Bourke NM; Keogh CA; Hegarty JE; O'Farrelly C
PLoS One; 2011; 6(11):e27866. PubMed ID: 22114715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
